Clinical Trial Update: FCM-R (Fludarabine, Cyclophosphamide, Mitoxantrone, Rituximab) in Previously Untreated Patients With Chronic Lymphocytic Leukemia (CLL) < 70 Years [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating FCM-R (Fludarabine, Cyclophosphamide, Mitoxantrone, Rituximab) in previously untreated patients with chronic lymphocytic leukemia under…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• FCM-R
• Fludarabine (Fludarabine)
• Mitoxantrone (mitoxantrone)
• Rituximab (rituximab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2018-12-06